Physician profile
Steven E Leonard
NPI 1588658975
$1,321.99
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $985 · 2020: $244 · 2021: $41.33 · 2022: $35.54 · 2023: $16.31.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $16.31.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $16.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $257.87 | 2019-2020 | |
| Glaxosmithkline, LLC. | $252.69 | 2019-2021 | |
| Novo Nordisk INC | $143.05 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $136.10 | 2019 | |
| Lilly USA, LLC | $88.87 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $85.59 | 2019-2022 | |
| Abbvie INC. | $63.41 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $61.84 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $55.17 | 2019 | |
| Amarin Pharma, INC. | $55.14 | 2019-2020 | |
| Amgen INC. | $50.72 | 2019-2020 | |
| Pfizer INC. | $15.37 | 2020 | |
| Ironshore Pharmaceuticals INC. | $15.03 | 2019 | |
| Shire North American Group INC | $14.88 | 2019 | |
| Grifols USA, LLC | $14.36 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $11.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Leonard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.